Literature DB >> 9254881

Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade.

P Rogalla1, K Drechsler, B Kazmierczak, V Rippe, U Bonk, J Bullerdiek.   

Abstract

The high-mobility-group (HMG) protein gene HMGI-C is apparently involved in the genesis of a variety of benign human solid tumors with rearrangements of chromosomal region 12q14-15 affecting the HMGI-C gene. So far, no expression of HMGI-C has been found in adult tissues, and no data are available on the expression of HMGI-C in primary human malignant tumors of epithelial origin. Therefore, we analysed the HMGI-C expression patterns in 44 breast cancer samples and 13 samples of nonmalignant adjacent tissue by hemi-nested reverse transcriptase-polymerase chain reaction for HMGI-C expression. There was no detectable expression of HMGI-C in any nonmalignant adjacent breast tissues analyzed. In contrast, we found expression in 20 of 44 breast cancer samples investigated. In invasive ductal tumors, expression was noted predominantly in tumors with high histologic grade: 17 of 21 breast cancer samples with histologic grade 3 but only three of 16 samples with histologic grades 1 or 2 showed expression of HMGI-C. In addition, all seven lobular breast cancer samples tested did not express HMGI-C. From these results, we concluded that HMGI-C expression may be of pathogenetic or prognostic importance in breast cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254881     DOI: 10.1002/(sici)1098-2744(199707)19:3<153::aid-mc2>3.0.co;2-f

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  36 in total

1.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

2.  Osteopoikilosis, short stature and mental retardation as key features of a new microdeletion syndrome on 12q14.

Authors:  Björn Menten; Karen Buysse; Farah Zahir; Jan Hellemans; Sara J Hamilton; Teresa Costa; Carrie Fagerstrom; George Anadiotis; Daniel Kingsbury; Barbara C McGillivray; Marco A Marra; Jan M Friedman; Frank Speleman; Geert Mortier
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

3.  Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.

Authors:  M Klotzbücher; A Wasserfall; U Fuhrmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  siRNA-Mediated Silencing of HMGA2 Induces Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma.

Authors:  Sahar Esmailzadeh; Behzad Mansoori; Ali Mohammadi; Dariush Shanehbandi; Behzad Baradaran
Journal:  J Gastrointest Cancer       Date:  2017-06

5.  HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.

Authors:  Miao Sun; Chun-Xiao Song; Hao Huang; Casey A Frankenberger; Devipriya Sankarasharma; Suzana Gomes; Ping Chen; Jianjun Chen; Kiran K Chada; Chuan He; Marsha R Rosner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

6.  HMGA2 inhibits apoptosis through interaction with ATR-CHK1 signaling complex in human cancer cells.

Authors:  Suchitra Natarajan; Sabine Hombach-Klonisch; Peter Dröge; Thomas Klonisch
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

7.  Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.

Authors:  Kai-Yin Chau; Guidalberto Manfioletti; Kam-Wa Cheung-Chau; Alfredo Fusco; Nathalie Dhomen; Jane C Sowden; Tetsuo Sasabe; Shizuo Mukai; Santa Jeremy Ono
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

8.  Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.

Authors:  Christopher J DiMaio; Frances Weis-Garcia; Emilia Bagiella; Laura H Tang; Peter J Allen
Journal:  Gastrointest Endosc       Date:  2015-09-25       Impact factor: 9.427

9.  Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer.

Authors:  C Langelotz; P Schmid; C Jakob; U Heider; K D Wernecke; K Possinger; O Sezer
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

10.  HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy.

Authors:  Heike Summer; Ou Li; Qiuye Bao; Lihong Zhan; Sabrina Peter; Padmapriya Sathiyanathan; Dana Henderson; Thomas Klonisch; Steven D Goodman; Peter Dröge
Journal:  Nucleic Acids Res       Date:  2009-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.